BECN1 and gastrointestinal stromal tumor: In addition, imatinib treatment was found to reduce the expression levels of miRNA-30a, which was found to inhibit the imatinib resistance of GIST cells by targeting Beclin-1, thus lessening the imatinib resistance related autophagy (Chen et al., 2020).